iStock-CasarsaGuru A new white paper has been published by leaders in the cannabis field, showcasing how to maximise clinical research and improve patient access to medical cannabis in the UK.
Following the approval of medical cannabis in the UK in November 2018, only two patients have gained access to full extract cannabis medicine through an NHS prescription. The authors have produced the white paper, ‘Medical cannabis in the UK: From principle to practice’ to help reduce the disparity in demand and supply.
The medical cannabis white paper puts forward potential solutions for healthcare workers prescribing medical cannabis, and for regulators in responding to the demand for access in the face of limited research for specific conditions – suggesting how to accelerate the integration of medical cannabis into UK healthcare.
Co-author, Anne Schlag, said: “This paper highlights current barriers to prescribing medical cannabis in the UK, and outlines potential solutions to overcome these. It is a tragedy that despite the legalisation of medical cannabis in November 2018, no new NHS prescriptions have been written , and patients, many of whom have been shown to benefit from the medicine, are still unable to access it.”
Medical Cannabis Network editor Stephanie Price spoke to co-author […]
read more here —> www.healtheuropa.eu